DETAILED ANALYSIS OF A MANUFACTURING ORGANISATION IN RELATION TO ELDER PHARMACEUTICALS LIMITED. PROJECT REPORT ON CONTENTS 1 S No 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17…

1.Agenda• Process and Access• Challenges and Success of Generics• Outlines of the Act• Legislative Language• Goals Letter• Next Steps• Questions and Answers2.…

1. IEA-Equity StrategyIndia Equity Analytics DIVISLAB : Good Growth Ahead"BUY"19th Dec, 201319th Dec 2013The company posted strong 2QFY4 results with net sales…

1. IEA-Equity StrategyIndia Equity Analytics DIVISLAB : Good Growth Ahead"BUY"19th Dec, 201319th Dec 2013The company posted strong 2QFY4 results with net sales…

CHAPTER 1; OVERVIEW OF DIVIâS LAB 1.1: INTRODUCTION TO DIVIâS LAB Established in the year 1990, with Research & Development as its prime fundamental, Divis Laboratories…

CHAPTER 1; OVERVIEW OF DIVIâS LAB 1.1: INTRODUCTION TO DIVIâS LAB Established in the year 1990, with Research & Development as its prime fundamental, Divis Laboratories…

CAPT Alicia M. Mozzachio, RPh, MPH Branch Chief, International Compliance Branch Office of Manufacturing & Product Quality Office of Compliance, CDER, FDA Post-Approval…

Original Drugs (Antibiotics) Vs Generic Drugs (Antibiotics) What we need to know ?? Dr Ankur Gupta, MD (Pharmacology) Medical Advisor, MSD Pharmaceuticals India- The Home…